Related Experiment Video
Updated: May 18, 2026

Assay to Measure Nucleocytoplasmic Transport in Real Time within Motor Neuron-like NSC-34 Cells
Published on: May 16, 2017
No GGGGCC-hexanucleotide repeat expansion in C9ORF72 in parkinsonism patients in Sweden
Chizuru Akimoto1, Lars Forsgren, Jan Linder
1Department of Pharmacology and Clinical Neuroscience, Umeå University, Umeå, Sweden. chizuru.akimoto@neuro.umu.se
Abstract:
An intronic GGGGCC-hexanucleotide repeat expansion in C9ORF72 was recently identified as a major cause of amyotrophic lateral sclerosis and frontotemporal dementia. Some amyotrophic lateral sclerosis patients have signs of parkinsonism, and many parkinsonism patients develop dementia. In this study we examined if the hexanucleotide repeat expansion was present in parkinsonism patients, to clarify if there could be a relationship between the repeat expansion and disease. We studied the size of the hexanucleotide repeat expansion in a well defined population-based cohort of 135 Parkinson's disease patients and 39 patients with atypical parkinsonism and compared with 645 Swedish control subjects. We found no correlation between Parkinson's disease or atypical parkinsonism and the size of the GGGGCC repeat expansion in C9ORF72. In conclusion, this GGGGCC-repeat expansion in C9ORF72 is not a cause of parkinsonism in the Swedish population.
Related Concept Videos
Parkinson Disease ll: Pathophysiology
Parkinson Disease l: Introduction
Huntington Disease l: Introduction
Single Nucleotide Polymorphisms-SNPs
Neural Regulation
Alterations in Muscle Tone lll
